http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021222891-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5cc1ba7221a8a65cfecc09c1733126f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2010-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-0045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-10
filingDate 2021-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e5e12282e92219e95d0e78a79c58c24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed46bb72cd2e10ad378a3ca2537aa1d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce67995b4a224e893da2587281a5bc76
publicationDate 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021222891-A1
titleOfInvention Ocular inserts with analyte capture and release agents
abstract An ocular device for insertion into the eye (for example, into a lacrimal punctum or a conjunctival sac) are described herein. The ocular device may continuously capture specific analytes from tear fluid. Several embodiments of the ocular device may have one or more open channels and pores that enable tears to drain naturally through while capturing specific analytes. A mechanism of detecting analytes in bodily fluids using materials comprised of DNAzymes and/or aptamers are described herein. Aptamers are oligonucleotide or peptide molecules that bind to a specific target molecule. DNAzymes are designed to catalyze a number of biological reactions (i.e., RNA cleavage, DNA cleavage, ligation, or phosphorylation reactions). A number of ways an ocular insert may capture analytes in tear fluid in vivo for subsequent in vitro analysis are described herein. Additionally, a specific mechanism for colorimetric detection of analytes using aptamer- and/or DNAzyme-crosslinked hydrogels are described herein.
priorityDate 2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016374648-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017135637-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009291508-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005163844-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018338713-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019237158-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451774801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09638
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412568307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119411

Total number of triples: 31.